Understand the bias, discover the truth in your news. Get Started
Forbes Article Rating

Medicaid Is Not A Test Lab For Foreign Price Controls

May 03, 2025 View Original Article
  • Bias Rating

    -4% Center

  • Reliability

    65% ReliableAverage

  • Policy Leaning

    -4% Center

  • Politician Portrayal

    -1% Negative

Bias Score Analysis

The A.I. bias rating includes policy and politician portrayal leanings based on the author’s tone found in the article using machine learning. Bias scores are on a scale of -100% to 100% with higher negative scores being more liberal and higher positive scores being more conservative, and 0% being neutral.

Sentiments

Overall Sentiment

-1% Negative

  •   Liberal
  •   Conservative
SentenceSentimentBias
Unlock this feature by upgrading to the Pro plan.

Bias Meter

Extremely
Liberal

Very
Liberal

Moderately
Liberal

Somewhat Liberal

Center

Somewhat Conservative

Moderately
Conservative

Very
Conservative

Extremely
Conservative

-100%
Liberal

100%
Conservative

Bias Meter

Contributing sentiments towards policy:

62% : MFN proponents like to frame the policy as a way to stop "foreign freeloading."
58% : Medicaid doesn't need price controls from other countries; it already imposes them here.
57% : Medicaid receives average discounts exceeding 50%.
56% : But we don't have to speculate -- decades of data already show what price controls do to innovation.
53% : The MFN proposal isn't tough on foreign freeloaders.
52% : Rep. Chip Roy, R-Texas, and 19 of his House colleagues have outlined exactly the right approach: restore fiscal responsibility to Medicaid through block grants or per-capita caps, tighten eligibility verification, and align incentives with outcomes.
51% : Instead of doubling down on price controls, Republicans should get serious about structural Medicaid reform.
47% : Under the program's existing "Best Price" rule, manufacturers must offer Medicaid the lowest price they give to any other buyer, plus pay steep, mandatory rebates.
47% : In practice, this could force companies to stop offering their drugs in Medicaid entirely.
47% : It would make Medicaid more expensive, less effective, and more dangerous -- not just to patients, but to the future of American medicine.
46% : In a desperate bid to claim fiscal discipline without touching entitlements, President Donald J. Trump is pushing congressional Republicans to adopt a "most favored nation" (MFN) drug pricing model for Medicaid.
45% : Importing foreign price controls is not a clever budget tactic.
44% : This policy would tie Medicaid reimbursements to the lowest prices paid in other developed countries -- countries where government officials dictate drug prices under threat of coercion, patent confiscation, or market exclusion.
43% : And thanks to federal law, exiting Medicaid also means forfeiting Medicare Part B coverage.
43% : One act of economic illiteracy would therefore sabotage both Medicaid and Medicare simultaneously.

*Our bias meter rating uses data science including sentiment analysis, machine learning and our proprietary algorithm for determining biases in news articles. Bias scores are on a scale of -100% to 100% with higher negative scores being more liberal and higher positive scores being more conservative, and 0% being neutral. The rating is an independent analysis and is not affiliated nor sponsored by the news source or any other organization.

Copy link